Subscribe
Sign In
Tag: CBT > Medical Cannabis Research Cannabinoids: Page 5
Colorado
Colorado State University Announces New Degree in Cannabis Science
Undergraduate degree program at Colorado State University-Pueblo will help to cultivate a new crop of cannabis experts and motivate research interest and efforts.
February 11, 2020
Top Stories
CBG: A New(er) Option for Cancer Treatment?
Preliminary studies show promise of a non-intoxicating stem cell cannabinoid against cancer cell lines in both isolated and synergistic drug preparations.
February 6, 2020
International
CBG and CBC Kill Gastrointestinal Cancer Cells in Preliminary Study
Funded by U.S. company Cannabics Pharmaceuticals, a firm focused on the development of cannabinoid therapies for cancer treatment, Israeli researchers have demonstrated the anti-tumor efficacy of CBG and CBC against human gastrointestinal cancer cell lines.
January 27, 2020
Distribution
Medical Cannabis Is Now Free in Sicily
Sicily’s health chief, Ruggero Razza, signed a decree Jan. 21 that will now allow medical cannabis patients free access to medical cannabis.
January 27, 2020
International
Super Drugs for Superbugs: How Cannabinoid Science Links CBG to MRSA Treatment
For nearly 40 years, the antimicrobial effects of cannabis-sourced compounds have been known to researchers. A new study sheds light on the particularly potent efficacy of an up-and-coming cannabinoid, CBG.
January 24, 2020
International
Newly Discovered Natural Cannabinoid THCP Offers Greater Potency Than THC
Recently published work from an Italian research team describes how THCP may help scientists understand why some cannabis chemovars are more potent than others.
January 10, 2020
International
Pre-Clinical Study Suggests CBG Is More Effective Than CBGA on Stomach and Bone Cancers
Researchers at Cannabics Pharmaceuticals in Israel have announced preliminary findings that show CBG may be more effective against human stomach and bone cancer cell lines than the acidic precursor, CBGA.
January 10, 2020
Industry Headlines
UCLA's Cannabis Research Initiative Awarded First Grant for Clinical Study from NIH
The National Institutes of Health has awarded a $3.5 million grant to UCLA's Cannabis Research Initiative to examine the pain-relieving effects of cannabis and its constituents in a clinical study. The study will also look at experiential differences associated with biological sex.
November 21, 2019
Kentucky
New Study Suggests Full-Spectrum Hemp CBD May Reduce or Eliminate Opioid Usage and Improve Quality of Life Measures
Ecofibre's Ananda Health Division reports promising results in largest-of-its-kind single-arm cohort study on opioid reduction and pain improvement using Kentucky-sourced hemp CBD.
November 14, 2019
International
Hope for Veterans Fighting PTSD: A New Study on Cannabis from Canada
Many suffering from post-traumatic stress disorder have sought out cannabis therapy as a safe and effective treatment for debilitating symptoms. A new analytical review of Canadian patient data suggests there is some evidence for its efficacy.
November 11, 2019
Legislation and Regulation
Senate Committee Hearing Emphasizes the Need for Policy Change to Increase Cannabis Research Access
This week, Senators Feinstein and Cornyn convened a panel of leading health experts to uncover the health impact of cannabis on consumers. Instead, they were hit with the realization that the only way to determine those impacts is through increased research access.
October 25, 2019
International
UK Research Institution Studying CBD for Symptoms of Psychosis in Parkinson's Patients
King's College London receives charitable donation from Parkinson's UK to begin a first-of-its-kind clinical trial to study the effects of CBD on psychosis symptoms in patients with early-stage Parkinson's disease.
October 21, 2019
Previous Page
Page 5 of 9
Next Page